Contact Us

Guidant Defibrillators
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Which Guidant cardiac defibrillator was implanted?

If other, what is the name of the defibrillator that was implanted?

Date the device was implanted:

Is the device still implanted?

What medical condition prompted the use of the device?

Please describe any problems or injuries caused by the product:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Boston Scientific recalls defibrillators

Apr 11, 2007 |

Boston Scientific Corp. has recalled some of its defibrillators, the FDA confirmed on its website.

A posting on the FDA's website detailed that on April 5, Natick, Mass.-based Boston Scientific recalled approximately 73,000 implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators, due to a flaw in the devices that can cause the batteries to wear out sooner than expected.

The company said that most patients would not be affected by the recall, but should contact their physicians about what steps to take next.

As of March 30, the company said it confirmed 19 field events with Guidant's devices, mostly related to premature battery depletion. There were no serious injuries or deaths reported.

Boston Scientific (NYSE: BSX) maintains a cardiac rhythm-management unit in Arden Hills that it acquired with Guidant Corp. It also has a Maple Grove facility that focuses on interventional cardiology technology, such as stents.

Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo